Advanced Wound Care Summit US TBC, Boston

It’s a chance for senior executives to address shared challenges around innovative product development, build meaningful partnerships, and sharpen their R and D and commercial strategies.

Whether an established wound care company, an emerging start-up, an SME, a regulator, a payer, or key opinion leader, this event serves your strategic and commercial goals.

To take this chance to uncover how leading figures are leveraging novel clinical trial designs, addressing reimbursement challenges surrounding skin substitute products, progressing next generation diagnostic innovations, and much more.

Speakers include:
Kris Kieswetter, Global Senior Director, Applied Medical Sciences, 3M
Ibraheem Badejo, Senior R and D Director, External Front End Innovation, Johnson and Johnson
David Armstrong, Professor of Surgery, University of Southern California
Mitch Sanders, Chief Scientific Officer, Alira
Kent Nielsen, Principal Wound Care Scientist, Coloplast
David Alper, Board Advisor, American Diabetes Association Prevention Alliance
Mike Griffiths, Chief Executive Officer, Advanced Oxygen Therapy Inc
Monique Rennie, VP of Medical Affairs and Reimbursement, MolecuLight
Chris Rao, Senior Vice President Clinical Operations, Alira
Chris Broderick, Chief Executive Officer, Merakris Therapeutics
Jignesh Patel, Head of Biologics and Regenerative Medicine, Smith and Nephew
Katherine Piette, Chief Executive Officer, Corstrata
Ira Herman, Senior Director, Biological Sciences, Precision Healing
Nikolai Sopko, Chief Scientific Officer and VP of R and D, PolarityTE
Jason Smith, Director of R and D, Integra LifeSciences
Kenny Carberry, Director of Clinical Development, Alira Health
Parth Desai, Principal, R42 Group
Jon Bloom, Chief Executive Officer, Podimetrics
Tom Serena, CEO and Founder, SerenaGroup